These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 6414954
21. [Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment]. László A, Csalánosiné Németh M, Joó I, Kiss E, Havass Z, Szenohradszki P. Orv Hetil; 1986 May 11; 127(19):1129-31. PubMed ID: 3714258 [No Abstract] [Full Text] [Related]
22. Lipid abnormalities in renal disease. Simon NM, Del Greco F. Ann Clin Lab Sci (1971); 1972 May 11; 2(3):186-90. PubMed ID: 4343276 [No Abstract] [Full Text] [Related]
24. Abnormal fat metabolism in chronic renal failure. Romics L, Makó J. Acta Med Acad Sci Hung; 1978 May 11; 35(3-4):233-40. PubMed ID: 227218 [Abstract] [Full Text] [Related]
25. [Comparative effects of hemodialysis using acetate and bicarbonate baths on lipid metabolism]. Lefebvre A. Nephrologie; 1983 May 11; 4(4-5):228. PubMed ID: 6664434 [Abstract] [Full Text] [Related]
26. Effects of two low-flux cellulose acetate dialysers on plasma lipids and lipoproteins--a cross-over trial. Ingram AJ, Parbtani A, Churchill DN. Nephrol Dial Transplant; 1998 Jun 11; 13(6):1452-7. PubMed ID: 9641175 [Abstract] [Full Text] [Related]
27. Increased lipoprotein-remnant formation in chronic renal failure. Nestel PJ, Fidge NH, Tan MH. N Engl J Med; 1982 Aug 05; 307(6):329-33. PubMed ID: 7088097 [Abstract] [Full Text] [Related]
28. Serum lipid metabolism abnormalities and change in lipoprotein contents in patients with advanced-stage renal disease. Tsumura M, Kinouchi T, Ono S, Nakajima T, Komoda T. Clin Chim Acta; 2001 Dec 05; 314(1-2):27-37. PubMed ID: 11718676 [Abstract] [Full Text] [Related]
32. Effects of castration and testosterone administration on serum lipoproteins and their apoproteins in male spontaneously hypertensive rat. Takeuchi N, Go S, Murase M, Nomura Y, Takase H, Uchida K. Endocrinology; 1986 May 05; 118(5):1787-94. PubMed ID: 3084207 [Abstract] [Full Text] [Related]
35. [Changes in the spectra of lipoproteins and phospholipids in the blood serum of patients with chronic renal failure placed on programmed hemodialysis]. Rozental' RL, Pirogova TF, Zezina LIu. Ter Arkh; 1989 May 05; 61(6):99-101. PubMed ID: 2799729 [Abstract] [Full Text] [Related]
36. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Elsharkawy MM, Youssef AM, Zayoon MY. Hemodial Int; 2006 Oct 05; 10 Suppl 2():S16-23. PubMed ID: 17022745 [Abstract] [Full Text] [Related]
37. De novo development of hypercholesterolaemia and increased HDL-cholesterol: apoprotein A-I ratio in patients with chronic renal failure following kidney transplantation. Kobayashi N, Okubo M, Marumo F. Proc Eur Dial Transplant Assoc; 1983 Oct 05; 19():505-9. PubMed ID: 6410382 [Abstract] [Full Text] [Related]
38. [Acute effects of sulodexide on the lipid profile and on antithrombin III in patients with chronic renal insufficiency in hemodialysis treatment]. Averna MR, Citarella P, Picone F, Capodicasa G, Galione A, Rini G, Notarbartolo A. Clin Ter; 1984 Jan 31; 108(2):111-4. PubMed ID: 6232045 [No Abstract] [Full Text] [Related]